Aclerastide Terminated Phase 3 Trials for Diabetic Foot Ulcers (DFUs) Treatment

TerminatedTreatment3 IdentifierTitleDrugs
NCT01840085Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use
NCT01830348Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers
NCT01849965Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers